Structure and organization of the human galactocerebrosidase (GALC) gene
- PMID: 7601472
- DOI: 10.1016/0888-7543(95)80230-j
Structure and organization of the human galactocerebrosidase (GALC) gene
Abstract
The deficiency of galactocerebrosidase (GALC; EC 3.2.1.46) is responsible for globoid cell leukodystrophy (GLD, Krabbe disease) in humans and certain animals. This enzyme catalyzes the lysosomal hydrolysis of specific galactolipids including galactosylceramide (galactocerebroside) and galactosylsphingosine (psychosine), among others. Recently we cloned the full-length human GALC cDNA using amino acid sequence information obtained from GALC purified from human urine and brain. In this communication we describe the organization of the human GALC gene. The gene, of nearly 60 kb, consists of 17 exons, which, aside from the first and last, are relatively small, ranging from 39 to 181 nucleotides. The 16 introns range from 247 nucleotides to nearly 12 kb. The 5' untranslated region is GC-rich, containing no perfect CAAT or TATA sequences, similar to genes for other lysosomal proteins. This information will be useful for studies to identify mutations causing low GALC activity in all patients with GLD and to identify the homologous gene in the important animal models.
Similar articles
-
Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.Genomics. 1997 Jun 1;42(2):319-24. doi: 10.1006/geno.1997.4744. Genomics. 1997. PMID: 9192853
-
Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.Biochem Mol Med. 1996 Aug;58(2):142-50. doi: 10.1006/bmme.1996.0042. Biochem Mol Med. 1996. PMID: 8812733
-
Analysis of the 5' flanking region of the human galactocerebrosidase (GALC) gene.Biochem Mol Med. 1997 Dec;62(2):159-64. doi: 10.1006/bmme.1997.2643. Biochem Mol Med. 1997. PMID: 9441867
-
Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.Hum Mutat. 1997;10(4):268-79. doi: 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1997. PMID: 9338580 Review.
-
Insights into the Pathogenesis and Treatment of Krabbe Disease.Pediatr Endocrinol Rev. 2016 Jun;13 Suppl 1:689-96. Pediatr Endocrinol Rev. 2016. PMID: 27491217 Review.
Cited by
-
Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements.Int J Neonatal Screen. 2024 Jan 28;10(1):10. doi: 10.3390/ijns10010010. Int J Neonatal Screen. 2024. PMID: 38390974 Free PMC article.
-
The Lysosomal Diseases Testing Laboratory: A review of the past 47 years.JIMD Rep. 2020 Apr 4;54(1):61-67. doi: 10.1002/jmd2.12117. eCollection 2020 Jul. JIMD Rep. 2020. PMID: 32685352 Free PMC article.
-
Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination.PLoS One. 2017 Nov 2;12(11):e0187217. doi: 10.1371/journal.pone.0187217. eCollection 2017. PLoS One. 2017. PMID: 29095858 Free PMC article.
-
Gene and Cellular Therapies for Leukodystrophies.Pharmaceutics. 2023 Oct 24;15(11):2522. doi: 10.3390/pharmaceutics15112522. Pharmaceutics. 2023. PMID: 38004502 Free PMC article. Review.
-
Sphingolipids and mitochondrial function, lessons learned from yeast.Microb Cell. 2014 Jun 25;1(7):210-224. doi: 10.15698/mic2014.07.156. Microb Cell. 2014. PMID: 28357246 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous